1-8 of 8
Ivan Van Riet
Close
Sort by
Journal Articles

Myeloid Derived Suppressor Cell Mediated AMPK Activation Regulates Multiple Myeloma Cell Survival

Kim De Veirman, Jo A. Van Ginderachter, Ivan Van Riet, Nathan De Beule, Susanne Lub, Eline Menu, PhD, Elke De Bruyne, PhD, Karin Vanderkerken, PhD, Els Van Valckenborgh, PhD
Journal: Blood
Blood (2014) 124 (21): 2009.
https://doi.org/10.1182/blood.V124.21.2009.2009
Published: 2014
Journal Articles

Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived From Multiple Myeloma Patients Is Associated with a Failure In the Deactivation of the NOTCH Pathway

Song Xu, Jinsong Hu, Dehui Xu, Isabelle Vande Broek, Xavier Leleu, Ben Van Camp, Karin Vanderkerken, Ivan Van Riet
Journal: Blood
Blood (2010) 116 (21): 1894.
https://doi.org/10.1182/blood.V116.21.1894.1894
Published: 2010
Journal Articles

Changes in Blood Circulating Cell Populations May Reflect the Anti-Angiogenic and Chemosensitizing Effects of Bortezomib and Thalidomide Treatment in Patients with Multiple Myelomatreatment in Patients with Multiple Myeloma.

Isabelle Vande Broek, MD, PhD, Xavier Leleu, Dan Duda, MD, PhD, Benjamin Van Camp, MD, PhD, Karin Vanderkerken, Ivan van Riet, PhD
Journal: Blood
Blood (2009) 114 (22): 2807.
https://doi.org/10.1182/blood.V114.22.2807.2807
Published: 2009
Journal Articles

MicroRNA Expression Analysis in Multiple Myeloma Plasma Cells and Cell Lines by a Quantitative Real-Time PCR Approach.

Marleen Bakkus, PhD, Sylvie Dujardin, MD, Ivan Van Riet, PhD, Marc De Waele, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 2472.
https://doi.org/10.1182/blood.V110.11.2472.2472
Published: 2007
Journal Articles

Role of the Hypoxic Bone Marrow Microenvironment in Multiple Myeloma Tumor Progression.

Kewal Asosingh, PhD, Hendrik De Raeve, MD, Mark de Ridder, MD, Guy A. Storme, MD, PhD, Angelo Willems, Ivan Van Riet, PhD, Benjamin Van Camp, MD, PhD, Karin Vanderkerken, PhD
Journal: Blood
Blood (2004) 104 (11): 2348.
https://doi.org/10.1182/blood.V104.11.2348.2348
Published: 2004
Journal Articles

Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity

Kewal Asosingh, Hendrik De Raeve, Eline Menu, Ivan Van Riet, Eric Van Marck, Benjamin Van Camp, Karin Vanderkerken
Journal: Blood
Blood (2004) 103 (8): 3131–3137.
https://doi.org/10.1182/blood-2003-08-2946
Published: 2004
Journal Articles

Multiple myeloma tumor progression in the 5T2MM murine model is a multistage and dynamic process of differentiation, proliferation, invasion, and apoptosis

Kewal Asosingh, Hendrik De Raeve, Ivan Van Riet, Benjamin Van Camp, Karin Vanderkerken
Journal: Blood
Blood (2003) 101 (8): 3136–3141.
https://doi.org/10.1182/blood-2002-10-3000
Published: 2003
Journal Articles

Insulin-Like Growth Factor-1 Acts as a Chemoattractant Factor for 5T2 Multiple Myeloma Cells

Karin Vanderkerken, Kewal Asosingh, Filip Braet, Ivan Van Riet, Ben Van Camp
Journal: Blood
Blood (1999) 93 (1): 235–241.
https://doi.org/10.1182/blood.V93.1.235
Published: 1999